Royal Bank of Canada’s Greenwich LifeSciences GLSI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Sell |
647
-1,087
| -63% | -$10.1K | ﹤0.01% | 6214 |
|
|
2025
Q1 | $16K | Buy |
1,734
+1,108
| +177% | +$10.2K | ﹤0.01% | 5611 |
|
|
2024
Q4 | $7K | Sell |
626
-444
| -41% | -$4.97K | ﹤0.01% | 5951 |
|
|
2024
Q3 | $16K | Buy |
1,070
+509
| +91% | +$7.61K | ﹤0.01% | 5704 |
|
|
2024
Q2 | $10K | Buy |
561
+547
| +3,907% | +$9.75K | ﹤0.01% | 5941 |
|
|
2024
Q1 | $0 | Sell |
14
-10
| -42% | – | ﹤0.01% | 6689 |
|
|
2023
Q4 | $0 | Buy |
24
+15
| +167% | – | ﹤0.01% | 6704 |
|
|
2023
Q3 | $0 | Sell |
9
-97
| -92% | – | ﹤0.01% | 6719 |
|
|
2023
Q2 | $1K | Sell |
106
-3
| -3% | -$28 | ﹤0.01% | 6541 |
|
|
2023
Q1 | $2K | Sell |
109
-591
| -84% | -$10.8K | ﹤0.01% | 6378 |
|
|
2022
Q4 | $11K | Sell |
700
-1
| -0.1% | -$16 | ﹤0.01% | 6031 |
|
|
2022
Q3 | $6K | Sell |
701
-699
| -50% | -$5.98K | ﹤0.01% | 6167 |
|
|
2022
Q2 | $12K | Sell |
1,400
-252
| -15% | -$2.16K | ﹤0.01% | 5837 |
|
|
2022
Q1 | $32K | Sell |
1,652
-564
| -25% | -$10.9K | ﹤0.01% | 5860 |
|
|
2021
Q4 | $54K | Sell |
2,216
-1,555
| -41% | -$37.9K | ﹤0.01% | 5803 |
|
|
2021
Q3 | $147K | Buy |
3,771
+695
| +23% | +$27.1K | ﹤0.01% | 4922 |
|
|
2021
Q2 | $138K | Buy |
3,076
+276
| +10% | +$12.4K | ﹤0.01% | 4900 |
|
|
2021
Q1 | $95K | Buy |
+2,800
| New | +$95K | ﹤0.01% | 5019 |
|